Correction to: Understanding the Sequelae of Invasive Meningococcal Disease in the United States.

Autor: Marshall GS; Norton Children's and the University of Louisville School of Medicine, Louisville, KY, USA., McCormick ZL; University of Utah School of Medicine, Salt Lake City, UT, USA., Johns JS; Vanderbilt University Medical Center, Nashville, TN, USA., Verduzco-Gutierrez M; University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Herrera-Restrepo O; GSK, FMC Tower Suite 1700, 2929 Walnut St, Philadelphia, PA, 19104, USA. oscar.x.herrera-restrepo@gsk.com., Harrison LH; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Publikováno v: Infectious diseases and therapy [Infect Dis Ther] 2024 Nov; Vol. 13 (11), pp. 2221-2222.

United States Physicians' Knowledge, Attitudes, and Practices Regarding Meningococcal Vaccination for Healthy Adolescents and Young Adults.

Autor: Herrera-Restrepo O; US Medical Affairs, Vaccines, GSK, Philadelphia, Pennsylvania. Electronic address: oscar.x.herrera-restrepo@gsk.com., Bunniran S; Surveys and Observational Studies, RTI Health Solutions, Research Triangle Park, North Carolina., Mond T; US Medical Affairs, Vaccines, GSK, Philadelphia, Pennsylvania., Davenport E; Biostatistics, RTI Health Solutions, Research Triangle Park, North Carolina., Wang J; Biostatistics, RTI Health Solutions, Research Triangle Park, North Carolina., Sweeney C; Surveys and Observational Studies, RTI Health Solutions, Research Triangle Park, North Carolina., Marshall GS; Pediatrics, Norton Children's and the University of Louisville School of Medicine, Louisville, Kentucky.

Publikováno v: The Journal of adolescent health : official publication of the Society for Adolescent Medicine [J Adolesc Health] 2024 Jun; Vol. 74 (6), pp. 1131-1138. Date of Electronic Publication: 2024 Feb 13.

Timing of Monovalent Vaccine Administration in Infants Receiving DTaP-based Combination Vaccines in the United States.

Autor: Marshall GS; From the Norton Children's and University of Louisville School of Medicine, Louisville, Kentucky., Petigara T; Merck & Co., Inc., Rahway, New Jersey., Liu Z; Merck & Co., Inc., Rahway, New Jersey., Wolfson L; Merck & Co., Inc., Rahway, New Jersey., Johnson D; Sanofi, Swiftwater, Pennsylvania., Goveia MG; Merck & Co., Inc., Rahway, New Jersey., Chen YT; Merck & Co., Inc., Rahway, New Jersey.

Publikováno v: The Pediatric infectious disease journal [Pediatr Infect Dis J] 2022 Sep 01; Vol. 41 (9), pp. 775-781. Date of Electronic Publication: 2022 Jun 24.

Clinical Features and Follow-up of Referred Children and Young People With Long COVID.

Autor: Weakley KE; From the Norton Children's, Louisville, KY.; Department of Pediatrics.; University of Louisville School of Medicine, Louisville, KY., Schikler A; University of Louisville School of Medicine, Louisville, KY., Green JV; From the Norton Children's, Louisville, KY.; Department of Pediatrics.; University of Louisville School of Medicine, Louisville, KY., Blatt DB; From the Norton Children's, Louisville, KY.; Department of Pediatrics.; University of Louisville School of Medicine, Louisville, KY., Barton SM; From the Norton Children's, Louisville, KY.; Department of Pediatrics.; University of Louisville School of Medicine, Louisville, KY., Statler VA; From the Norton Children's, Louisville, KY.; Department of Pediatrics.; University of Louisville School of Medicine, Louisville, KY., Feygin Y; Department of Pediatrics.; University of Louisville School of Medicine, Louisville, KY., Marshall GS; From the Norton Children's, Louisville, KY.; Department of Pediatrics.; University of Louisville School of Medicine, Louisville, KY.

Publikováno v: The Pediatric infectious disease journal [Pediatr Infect Dis J] 2023 Dec 01; Vol. 42 (12), pp. 1093-1099. Date of Electronic Publication: 2023 Sep 21.

A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB).

Autor: Marshall GS; Department of Pediatric Infectious Diseases, Norton Children's and University of Louisville School of Medicine, Louisville, KY, USA., Abbing-Karahagopian V; Epidemiology, Value Evidence and Outcomes, GlaxoSmithKline Vaccines, Amsterdam, The Netherlands., Marshall HS; Department of Pediatrics, Women's and Children's Health Network and Adelaide Medical School and Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia., Cenci S; Safety Department, GlaxoSmithKline, Siena, Italy., Conway JH; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health Clinical Sciences Center, Madison, WI, USA., Occhipinti E; Safety Department, GlaxoSmithKline, Siena, Italy., Bekkat-Berkani R; Global Medical Affairs, GlaxoSmithKline, Rockville, MD, USA., Banzhoff A; Global Medical Affairs, GlaxoSmithKline Vaccines, Marburg, Germany., Sohn WY; Global Medical Affairs, GlaxoSmithKline, Rockville, MD, USA.

Publikováno v: Expert review of vaccines [Expert Rev Vaccines] 2023 Jan-Dec; Vol. 22 (1), pp. 530-544.